Company / Shares Outstanding
Aclaris Therapeutics, Inc. Shares Outstanding History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
107.9M
FY2025
5-year range
45.1M / 107.9M
FY2021-FY2025
Trend
+52.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shares Outstanding has increased for 8 consecutive years, from 26059181.00 in FY2017 to 107850124.00 in FY2025.
Based on SEC 10-K filings.
107850124.00 in FY2025 with a 5-year CAGR of +21.1%.
Increased from 66688647.00 to 107850124.00 over the past 2 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +20.8%
- 5-Year CAGR
- +21.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- Aclaris Therapeutics, Inc.'s shares outstanding has grown for 8 consecutive years.
- In FY2025, shares outstanding increased 52.1% year-over-year.
- Lowest shares outstanding in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -5.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 107.9M | +52.1% |
| FY2024 | 70.9M | +6.3% |
| FY2023 | 66.7M | +8.9% |
| FY2022 | 61.2M | +35.7% |
| FY2021 | 45.1M | +8.7% |
| FY2020 | 41.5M | +0.7% |
| FY2019 | 41.2M | +33.6% |
| FY2018 | 30.9M | +18.4% |
| FY2017 | 26.1M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026